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ABSTRACT  1 
Lowland-dwelling populations exhibit persistent sympathetic hyperactivity at altitude that alter 2 
vascular function. High altitude populations, such as Sherpa, have previously exhibited greater 3 
peripheral blood flow in response to acute stress than Lowlanders which may be explained 4 
through lower sympathetic activity. Our purpose was to determine if Sherpa exhibit lower 5 
sympathetic reactivity to stress than Lowlanders. Muscle sympathetic activity (MSNA; 6 
microneurography) was measured at rest in Lowlanders (n=14; age=27±6yrs) at 344m and 7 
following a 8-9 days at 5050m. Sherpa (age=32±11yrs) were tested at 5050m (n=8). 8 
Neurovascular reactivity (ie. change in MSNA patterns) was measured during maximal end-9 
expiratory apnea, isometric hand-grip (IHG; 30% maximal voluntary contraction for 2-minutes) 10 
and post-exercise circulatory occlusion (PECO; 3-minutes). Burst frequency (bursts/min), 11 
incidence (bursts/100HB), and total normalized SNA (au/min) was analyzed at rest, immediately 12 
prior  to apnea breakpoint, and during the last minute of IHG and PECO. Vascular responses to 13 
apnea, IHG, and PECO were also measured. MSNA reactivity to apnea was smaller in Sherpa 14 
than Lowlanders at 5050m, though blood pressure responses were similar between groups. 15 
MSNA increases in Lowlanders during apnea at 5050m were significantly lower than at 344m 16 
(P<0.05), indicating possible sympathetic ceiling was reached in Lowlanders at 5050m. MSNA 17 
increased similarly during IHG/PECO in Lowlanders at both 334m and 5050m, and Sherpa at 18 
5050m, while vascular changes (mean brachial arterial pressure, contralateral brachial 19 
flow/resistance) were similar between groups. Sherpa demonstrate overall lower sympathetic 20 
reactivity which may be a result of heightened vascular responsiveness to potential apneic stress 21 
at altitude.  22 




 The response to both acute  (18, 21, 30, 31, 36)  and chronic (e.g. altitude)  (6, 13, 22, 25)  25 
reductions of oxygen availability in lowland dwelling populations is an increase in basal efferent 26 
sympathetic activity (SNA). This sympathoexcitation occurs in conjunction with local dilation to 27 
facilitate blood flow redistribution and oxygen delivery to critical tissues. Previous findings also 28 
show an augmented SNA response to exercise (i.e. increased sympathetic reactivity) under acute 29 
hypoxic conditions  (18, 33) . Whether a similar potentiation occurs during chronic hypoxia is 30 
unknown.  As Lowlanders exhibit heightened SNA at altitude, we propose a similar potentiation 31 
of sympathetic reactivity to additional stress.  Furthermore, whether similar responses are evident 32 
in those exposed to long duration hypoxia, such as high altitude natives has not been studied. 33 
Nepalese/Tibetan Sherpa have resided at high altitude (>2500m) for thousands of years, allowing 34 
for unique evolutionary phenotypic adaptations under chronic hypoxia exposure. This includes 35 
not only cardiovascular adaptations that allow for increased oxygen delivery and metabolism at 36 
the local tissue  (7, 9, 41) , but also overall lower SNA at rest compared to Lowlanders at altitude  37 
(35) . Limited data suggest that Sherpa exhibit an improved ability to increase systemic blood 38 
flow at altitude  (9, 32) , while also showing greater capillary density within skeletal muscle  (19)  39 
and improved ability to increase leg blood flow  (32) . Given our previous findings have shown 40 
that Sherpa exhibit lower basal MSNA compared to Lowlanders  (35) ; we hypothesize that these 41 
differences in vascular function between Lowlanders and Sherpa may also translate to lower 42 
sympathetic reactivity to acute apneic/exercise stress.  43 
 44 
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To address the hypothesis, we performed microneurographic recordings of efferent post-45 
ganglionic nerve activity in Lowland dwellers at low (344m) and high (5050m) altitudes and in a 46 
group of native Sherpa at altitude (5050m). This was complemented with brachial 47 
ultrasonography to determine the effect of heightened sympathetic stress on vascular function 48 
during stress in Sherpa and acclimatized Lowlanders.   49 
 50 
METHODS 51 
This study was carried out within the framework of the 2016 UBC Nepal Expedition to the 52 
Ev-K2-CNR Research Facility (5050m)  (40) . Though participants took part in a number of 53 
independent investigations, experiments were organized to ensure no contamination between 54 
studies, and each study addressed distinct a priori research questions.  Baseline demographics, 55 
cardiovascular characteristics and heart rate responses to apnea have been previously reported 56 
from Lowlanders and Sherpa at altitude  (3, 38) , while metrics of basal SNA have also been 57 
previously reported by our group  (35) . Therefore, basal SNA data is included as a complement 58 
for the novel independent analyses related to sympathetic reactivity. 59 
 60 
Study Participants 61 
Fourteen Lowlanders (27±6yrs; 2 female) and ten Sherpa (32±11yrs; 0 female) from the 62 
Khumbu region of Nepal participated after providing informed written consent in their native 63 
language. Procedures were explained in Nepalese and English as needed, and were approved by 64 
the University of Alberta Biomedical Research Ethics Board, University of British Columbia 65 
Clinical Research Ethics Board, and Nepal Health Research Council. Participants were free of 66 
ventilatory, cardiovascular, metabolic, and neurological disorders as determined by a self-67 
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reported health history questionnaire. Four Sherpa were self-reported smokers (0.4±0.7 pack 68 
years). 69 
 70 
Testing Location(s) 71 
The ascent profile and testing schedules are outlined in Supplemental Figures 1 72 
(https://doi.org/10.6084/m9.figshare.8066717), 2 (https://doi.org/10.6084/m9.figshare.8066711), 73 
and 3 (https://doi.org/10.6084/m9.figshare.8066714.v1). Pre-expedition testing of Lowlanders 74 
(n=14) was performed at 344m (Kelowna, Canada). To match the ascent profile and 75 
acclimatization process between groups, Sherpa were flown to Kathmandu, Nepal (1400 m), 76 
where they resided between 5-15 days.  Both Lowlanders and Sherpa flew to Lukla, Nepal 77 
(2840m) and followed a 9-10 day ascent. One lowlander was administered oral acetazolamide 78 
(half life - 4 hrs) and another was administered an intramuscular injection of dexamethasone 79 
(half life – 3 hours) following 4 days arrival at 5050m for the treatment of acute mountain 80 
sickness; however, both were tested after a 48-hour washout. Sherpa were not on any medication 81 
and were tested on days 1-3 following arrival at 5050m, while Lowlanders were tested between 82 
days 1-10 (Supplemental figure 2).  83 
 84 
Study Protocol 85 
Following instrumentation, basal SNA and cardiovascular function were measured during 10 86 
minutes of quiet rest. Sympathetic reactivity was subsequently assessed using two protocols: 1) a 87 
volitional end-expiratory apnea at functional residual capacity  (23)  and 2) isometric hand-grip 88 
(IHG) performed for 2 min followed by 3 min of post-exercise circulatory occlusion (PECO). 89 
Prior to apnea, an investigator paced the participants’ breathing (2-3 breaths) to maintain rate and 90 
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depth, while preventing hyperventilation. Participants were then instructed to “hold their breath 91 
for as long as possible. Participants performed IHG at 30% of their previously determined 92 
maximal voluntary contraction using handgrip dynamometer (Grip Force Transducer; 93 
ADInstruments, Australia). Immediately following 2 minutes of IHG, a manual blood pressure 94 
cuff was inflated (>200mmHg) for 3 minutes to stimulate post-exercise ischemia while the limb 95 
was relaxed.  The apnea protocol always preceded IHG/PECO protocol. 96 
 97 
Experimental Measures 98 
All participants were tested in the supine position.  ECG (Lead II) and the arterial blood 99 
pressure waveforms (finger photoplethysmography; Finometer Pro, Finapres Medical Systems, 100 
Netherlands) were collected continuously at 1 KHz (ADInstruments, Chart Pro v8.3.1, 101 
Australia). Heart rate (HR) was calculated from the ECG R-R interval. Beat-by-beat cardiac 102 
output (CO) was calculated using the Model Flow algorithm and used to calculate total 103 
peripheral resistance (TPR = MAP/CO).  Beat-by-beat mean (MAP), systolic (SBP) and diastolic 104 
(DBP) pressures were calculated from the arterial pressure waveform that was calibrated against 105 
manual sphygmometry.  106 
 107 
Muscle Sympathetic Nerve Activity 108 
Microneurography was used to directly measure efferent muscle sympathetic vasomotor nerve 109 
activity (MSNA) (11, 35, 37) . A tungsten microelectrode (200μm diameter, 35 mm long, tapered 110 
to a 1-5 μm uninsulated tip) was inserted percutaneous into the peroneal (common fibular) nerve, 111 
with an uncoated tungsten reference electrode inserted subcutaneously 1-3 cm from the recording 112 
site. The recording electrode was manipulated until a pulse-synchronous bursting pattern was 113 
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identifiable in response to apnea but not a loud noise  (4) . The raw MSNA signal was amplified 114 
(1000x pre-amplifier and 100x variable gain isolated amplifier), band pass filtered (700-115 
2,000Hz), rectified, and integrated (decay constant 0.1s) to obtain a mean voltage neurogram 116 
(model 662C-3; Iowa University Bioengineering; USA). Both raw and integrated signals were 117 
sampled at 10 KHz (ADInstruments, Chart Pro v8.3.1; Australia). 118 
 119 
Vascular Ultrasonography 120 
 Of the 22 participants tested, ultrasonograhy was successfully obtained a subset of 121 
Lowlanders (n= 8) and Sherpa (n = 4). Ultrasonography was used to measure brachial artery 122 
(BA) diameter, Doppler velocity (BAv), and flow (BAF) in the non-exercising arm at baseline 123 
and during the IHG/PECO protocols (12 ~MHz linear array transducer; Vivid Q, GE 124 
Healthcare). Probe insonation-angle was kept constant (60°) across all tests. Video capture was 125 
used for recording vessel diameter (DVI2USB3.0; Epiphan Systems, Canada) and was stored 126 
off-line in audio video interleave format for future analysis with edge detection software 127 
(Brachial Analyzer, Medical Imaging Applications, USA). Image analysis of data was performed 128 
at 30Hz following visual confirmation (SAB) of the region of interest to ensure clearly 129 
distinguishable lumen walls. BA flow velocity waveforms were converted from Doppler audio 130 
signals (qDAT; Penn State, USA)  (14)  and stored offline at 1 KHz (ADInstruments, Chart Pro 131 
v8.3.1).  132 
 133 
Data and Statistical Analysis 134 
  Resting MSNA and cardiovascular data was averaged over ~10 minutes. MSNA bursts were 135 
identified using a semi-automated detection algorithm (Chart Pro 8.3.1) and confirmed by a 136 
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trained observer (SAB). Resting MSNA was quantified as burst frequency (bursts/min), 137 
incidence (bursts/100 HB), and normalized burst amplitude (% of maximal burst size at baseline) 138 
and area (area under the curve, [au]).  For the apnea protocol, MSNA and cardiovascular data 139 
were analyzed from the final 10 cardiac cycles prior to volitional breakpoint.  Cardiovascular 140 
post-apnea nadir (SpO2, HR) and peak (SBP, DBP, MAP) responses were obtained in 10-15 141 
seconds post breakpoint. MSNA bursts during the apnea were calculated as the burst area (area 142 
under the curve, [au]) during the last 10 cardiac cycles prior to volitional breakpoint. Burst area 143 
was normalized SNA (au/min) during baseline and apnea to account for variations in cardiac 144 
cycle length and burst width (3) . In addition, the average likelihood (%) of a burst occurring 145 
during a given cardiac cycle for apneas was calculated across participants. Sympathetic reactivity 146 
to apnea was assessed as the increase in normalized burst area was compared between baseline 147 
and end-apnea. MSNA (frequency, incidence and normalized amplitude) and cardiovascular data 148 
(HR, blood pressure, TPR, and BAF) were averaged during the last minute of both IHG and 149 
PECO.  Sympathetic reactivity was assessed as the increase in MSNA from baseline to IHG and 150 
PECO. Finally, an indirect measure of neurovascular transduction was performed to determine 151 
the translation of sympathetic outflow on vascular outcomes (delta change in TPR over the delta 152 
change in delta burst frequency [au]) across groups during the IHG/PECO protocols. 153 
 154 
Results are reported as mean ± standard deviation (SD) with the exception of baseline burst 155 
amplitude, which is reported as median ± interquartile range (IQR) to account for differences in 156 
amplitude distribution between conditions.  Multiple comparisons were assessed for all 157 
measurements using pre-planned contrasts of Lowlanders from low to high altitude  (paired t-158 
tests), and Lowlanders to Sherpa at high altitude (unpaired t-tests) with an adjusted alpha (α’) 159 
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value corrected for multiple comparisons (c). This was performed by adjusting the a priori alpha 160 
(α, 0.05) using the experiment-wise error rate (αe)  (3, 15) :  161 
 162 
 163 
  164 
For normalized bursts amplitude, and vascular responses during baseline, IHG, and PECO 165 
protocols, a two-way repeated measures ANOVA compared the main and interaction effects in 166 
the distributions between conditions. Statistical analysis for normalized total peak SNA and change in 167 
mean arterial pressure was performed via one-way ANOVA between Lowlanders at low altitude, 168 
Lowlanders at High Altitude.  To address the potential effect of duration at altitude on resting 169 
MSNA; a secondary analysis via Pearson’s moment correlation analysis of dependent variables 170 
was performed in this study. Finally, ANCOVA analysis was used to control for duration at 171 
altitude. All statistical analyses were performed using SigmaPlot 13 (Systat Software, Chicago, 172 
IL).   173 
 174 
RESULTS 175 
Fourteen lowlanders were successfully tested at 344m and again at 5050m. Two 176 
Lowlanders reported having mild acute mountain sickness (AMS) on the day of testing (Lake 177 
Louise scores of 3). However, the data from these two subjects were comparable to the averaged 178 
responses and therefore included in the main analyses. Eight of the ten Sherpa who descended to 179 
Kathmandu were successfully tested at 5050m.  No relationship was shown in this study between 180 
duration after arriving at 5050m and resting MSNA in either Lowlanders  (Burst Frequency r2= 181 
0.160, p= 0.065) or Sherpa (Burst Frequency r2 = 0.001, p=0.937).  Baseline cardiovascular and 182 
𝑎′ = 𝛼𝑐  𝛼 = 1 − (1 − 𝛼)
Downloaded from www.physiology.org/journal/ajpregu by Jonathan Moore (082.132.245.171) on January 8, 2020.
 10
autonomic characteristics for both Sherpa and Lowlanders are listed in Table 1. SBP, DBP, 183 
MAP, CO, TPR, and SpO2 were not different between lowlanders and Sherpa at 5050m  184 
 185 
Baseline Neurovascular Characteristics in Sherpa and Lowlanders 186 
Resting MSNA values for Sherpa and Lowlanders have been reported previously 187 
reported  (35) , but are displayed in Tables 1 for completeness.  Briefly, Lowlanders burst 188 
frequency tripled (11 ± 5 bursts/ min to 30 ± 7 bursts/ min; p<0.001) while burst incidence 189 
doubled (25 ± 13 bursts/100 HB to 50 ± 15 bursts/ 100 HB; p<0.001) following several days at 190 
high altitude. At 5050m, Sherpa had a lower burst frequency (23 ± 11 bursts/min; p<0.05) and 191 
incidence (30 ± 13 bursts/100 HB; p<0.05) compared to Lowlanders at 5050m. At altitude the 192 
distribution of normalized burst area was also shifted towards larger sized bursts in Lowlanders, 193 
with the burst amplitude distributions in the Sherpa being similar to that of Lowlanders at 194 
5050m.  After taking into account differences in both frequency and amplitude distribution, total 195 
basal sympathetic activity was similar in Sherpa (1103 ± 520 au/min) and Lowlanders at 5050m 196 
(1320 ± 520 au/min; P=0.385) with both being higher than observed in lowlanders at low altitude 197 
(451 ± 206 au/min; p<0.05). 198 
Sympathetic Reactivity to Apnea in Lowlanders and Sherpa 199 
Sympathetic neurovascular reactivity during apnea was assessed in 14 Lowlanders at low 200 
and high altitude, and 8 Sherpa assessed at 5050m.  At low altitude, Lowlanders had an apnea 201 
duration of 30.4 ± 11.1 s (range 15-74s) which was reduced to 15.4 ± 5.3 s (range 9-27s) 202 
(P<0.001) at 5050m. Lowlanders SpO2 nadir post-apnea was 78 ± 7%. Sherpa apnea duration 203 
(15.8 ± 2.6; Range 12-19s; P = 0.84) and saturation (75 ± 5%; P=0.329) post-apnea were not 204 
different to that of Lowlanders.  205 
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Apnea across all groups and conditions produced a very robust increase in MSNA driven 206 
by changes in both burst occurrence and burst area (Figures 1-3). Apnea at low altitude was 207 
associated with a significant increase in MSNA in Lowlanders (normalized total area +31359 ± 208 
30383 au/min compared to baseline; P<0.01). While apnea at altitude resulted in the largest burst 209 
augmentation and increase in burst occurrence (Figure 2), this occurred over a longer time due to 210 
a previously reported bradycardia response  (3)  Thus, the au/min response to apnea tended to be 211 
less at high altitude (+17711 ± 11018 au/min) versus low altitude (+31359 ± 30434 au/min; 212 
p=0.063).  Interestingly, 5 out of the 14 Lowlanders had “prolongation” of sympathetic bursts 213 
during apnea at high altitude that did not represent normal burst firing characteristics.  More 214 
specifically, the cyclical modulation of efferent bursts activity was altered at 5050m such that 215 
bursts became broader and less peaked, encompassing a larger portion of the cardiac cycle 216 
(Figure 1). In addition, there was a brief period post-apnea where no bursts occurred (approx.5-217 
10 seconds) immediately following volitional breakpoint, after which ‘characteristic bursts’ 218 
returned to those observed pre-apnea. In contrast, Sherpa sympathetic responses to apnea (+7708 219 
± 4312 au/min) were significantly lower than Lowlanders at low altitude (P=0.048) and at 220 
5050m (P=0.027).  Additionally, there were no observed cases of “prolonged” bursts in Sherpa 221 
neurograms.   222 
Apnea resulted in a significant increase in mean blood pressure in all three groups; 34 ± 223 
13 mmHg in Lowlanders at low altitude, 35 ± 20 mmHg in Lowlanders at 5050m and 23 ± 8 224 
mmHg in Sherpa at 5050m (all P<0.01 with respect to baseline) (Figure 3).  The increase in 225 
MAP associated with apnea was smallest in Sherpa (P=0.028 when compared to Lowlanders at 226 
334m).  When these responses were considered together Sherpa had higher vascular 227 
responsiveness to sympathetic activation during apnea (3.70 ± 1.90 mmHg/au/min x 10-3) 228 
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compared to Lowlander at low (1.84 ± 1.17 mmHg/au/min x 10-3, P<0.01) but not high (2.62 ± 229 
1.81 mmHg/au/min x 10-3, P=0.227) altitude. 230 
 231 
Sympathetic and Vascular Reactivity to Isometric Hand Grip and Post Exercise 232 
Circulatory Occlusion 233 
 Sympathetic neurovascular reactivity during the IHG/PECO protocols was assessed in 14 234 
Lowlanders at low and high altitude, and was successfully collected in 6 Sherpa 5050m. At 235 
altitude, Sherpa exhibited an overall lower burst frequency, incidence and total MSNA during 236 
the BL, IHG and PECO compared to acclimatized Lowlanders (Figure 4, each P<0.001). During 237 
IHG burst frequency (+17 ± 9, +18 ± 13, and +16 ± 12 bursts/min; all P<0.001), burst incidence 238 
(+14 ± 15, +5 ± 15, and +13 ± 13 bursts/100 HB; all P<0.001) and total MSNA (+1429 ± 893, 239 
+1247 ± 1178, and +1827 ± 1361 au/min; all P<0.001) were elevated significantly in Lowlanders 240 
at 344m and 5050m, and Sherpa at 5050m respectively (Figure 4).  No further increase in burst 241 
frequency or total MSNA occurred between IHG and PECO, although burst incidence climbed 242 
due to the concurrent return of heart rate to baseline during PECO (Figure 5). The increase in 243 
MSNA occurring with IHG/PECO was not different between groups. 244 
While Sherpa tended to have an overall lower blood pressure (Main effect of group 245 
P=0.32; P=0.27 versus Lowlanders in Kelowna; P=0.93 versus Lowlanders at 5050m), the 246 
absolute change in blood pressure response to IHG and PECO were similar between Sherpa 247 
(+15± 4 and +12± 6 mmHg) and Lowlanders (+15± 6 and +12± 8 mmHg) at 5050m (Figure 5; 248 
P=0.829 for IHG, P=0.778 for PECO).   The change in total peripheral resistance was also 249 
similar between Sherpa (+2.6± 2.8 and +2.9± 2.9 mmHg/L/min) and Lowlanders  (-0.7± 1.9 and 250 
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+0.6± 1.7 mmHg/L/min)  at 5050m (P=0.791 for IHG, P=0.836 for PECO). Thus, unlike the 251 
apnea protocol we did not detect significant differences in neurovascular reactivity during IHG / 252 
PECO stress with altitude (in Lowlanders) or between groups (at 5050m).  Indirect transduction 253 
analysis revealed that Sherpa showed greater vascular transduction than Lowlanders at 344m 254 
(+151.7± 73.1 versus -74.7 ±184.7 au; P=0.015), but not Lowlanders at 5050m (0.9± 262.0 au; 255 
P=0.198), during the IHG protocol. However, the transduction response was similar across all 256 
groups during the PECO protocol, respectively (+178.2 ± 142.5; +214.0± 131.0 [ P=0.657 versus 257 
Sherpa]; and  +7.5 ± 279.6 [P =0.187 versus Sherpa] au).    258 
 259 
Forearm Blood Flow Reactivity in Lowlanders and Sherpa 260 
 Brachial artery blood flow was successfully analyzed in a subset of 8 Lowlanders and 4 261 
Sherpa during the HG/PECO protocol (Figure 6). Basal forearm blood flow was not different 262 
between Lowlanders at 344m (46± 39 mL/min), 5050m (22± 42 mL/min), or Sherpa at 5050m 263 
(56± 24 ml/min) (Main effect of Group, P=0.080). Both IHG and PECO saw no change in 264 
contralateral brachial blood flow for Sherpa (+8± 23, P=0.836 and +11± 38 mL/min, P=0.522 265 
respectively) and Lowlanders  (+29± 25, P=0.624 and +22± 42 mL/min, P= 0.644 respectively) 266 
at 5050m.  The HG and PECO protocols did not result in a change in contralateral brachial 267 
resistance for Sherpa (-0.3± 1.1, P=0.879 and 0.1± 0.8 mmHg/mL/min, P=0.987 respectively) 268 
and Lowlanders (-0.6± 1.0, P=0.945 and -0.2± 0.9 mmHg/mL/min, P=0.898 respectively) at 269 
5050m, similar to blood pressure results (above). However, analysis of conductance proved more 270 
sensitive, indicating significant main effect for brachial artery conductance (P=0.049), with 271 
Lowlanders having a higher brachial artery conductance at altitude than Sherpa (P=0.047, Figure 272 
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6). Nonetheless, there remained no absolute change in conductance during IHG and PECO for 273 
either Sherpa (-0.1± 0.3 and -0.1± 0.5 mmHg/mL/min) or Lowlanders (+0.2± 0.3 and +0.1± 0.5 274 
mmHg/mL/min) at 5050m. 275 
 276 
DISCUSSION 277 
 This study demonstrates that sympathetic neural activation (i.e. increases in MSNA) in 278 
response to acute apneic stress appears lower in Lowlanders following acclimatization. However, 279 
this is due to the unique nature maximal volitional apneas. Nonetheless, Sherpa had a lesser 280 
response compared to acclimatizing Lowlanders at 5050m and Lowlanders at low altitude 281 
(334m). This lower MSNA response in Sherpa was offset by a greater vascular reactivity to 282 
sympathetic activation.  During isometric hand-grip and post-exercise circulatory occlusion, 283 
sympathetic activation was observed to be much lower than the apneic stress, and no differences 284 
were noted between groups with respect to sympathetic activation or vascular responses.   285 
 286 
MSNA responses to apneic and hand-grip / post-exercise circulatory occlusion stressors 287 
 Apnea proved to be a significant sympathetic stressor, both at low and high altitude. 288 
Although acclimatized Lowlanders demonstrated 100% burst occurrence and the greatest burst 289 
augmentation (i.e. increase in burst area), normalized total activity remained lower than that 290 
measured at low altitude.  This was due to a previously reported bradycardia 16 that limits burst 291 
frequency.  Thus, an apparent “sympathetic ceiling” may be reached during apnea in chronic 292 
hypoxic conditions. Despite similar apnea durations and desaturation in Sherpa compared to 293 
acclimatized Lowlanders, the Sherpa demonstrated a lower burst occurrence, lower burst 294 
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augmentation and a lower total MSNA response to apnea.  Importantly, this occurred without an 295 
apparent limitation on burst frequency (i.e. no bradycardia).  These data indicate that Sherpa are 296 
less responsive to apneic stress under the same hypoxic conditions as acclimatized lowlanders.  297 
This also suggests that Sherpa have a greater functional sympathetic reserve, whereby they may 298 
theoretically be able to increase MSNA more than observed in the current study. In contrast to 299 
apneic stress, the MSNA response to the IHG/PECO protocol was appreciably smaller (although 300 
not assessed statistically).  Although a main effect of group was present, with acclimatized 301 
Lowlanders having the highest activity, all three groups exhibited similar increases in MSNA 302 
burst frequency, incidence, and total activity during IHG/PECO.   303 
  304 
Previous studies in Lowlanders under acute hypoxic exposure demonstrate further MSNA 305 
potentiation during dynamic exercise compared to normoxia. (18, 34)   Since the ascent to 306 
altitude causes further reductions in oxygen availability to the local tissue alongside concurrent 307 
MSNA augmentation, we hypothesized that altitude would also be associated with an augmented 308 
SNA response to IHG and PECO.  However, the lack of difference in the response at low and 309 
high altitudes demonstrate that chronic hypoxic stress compounded with further metabolic 310 
activation (albeit in one isolated limb during an isometric exercise) does not alter the MSNA 311 
response. Therefore, MSNA reactivity to metaboreflex stress appears preserved in acclimatized 312 
Lowlanders. We believe that this may be explained through several myogenic adaptations during 313 
acclimatization that favor anaerobic metabolism under chronic hypoxia exposure. With long-314 
term exposure to altitude there has been previously noted reductions of muscle oxidative 315 
capacity  (16)  associated with muscle atrophy and catabolism  (2)  in addition to a shift away 316 
from FA enzyme oxidation during rest and exercise  (29) . These potential adaptations during 317 
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longer periods of residency at altitude would improve anaerobic metabolism, reduce metabolic 318 
strain and overall sympathetic activation compared to exertion during an acute period of hypoxia 319 
exposure. These adaptations may be time dependant, with shorter periods of exposure not 320 
appearing to show any significant changes in skeletal muscle function or morphology  (26) . 321 
Therefore, any potential myogenic adaptations that may exist in the first week of acclimatization 322 
for Lowlanders does not appear to directly affect efferent sympathetic outflow. Previous data 323 
have indicated lower mitochondrial density  (19) , improved ATP to O2 yield and greater energy 324 
production at a lower oxygen cost in Sherpa  (17) . Sherpa have also previously demonstrated 325 
increased ability to augment femoral blood flow velocity post-circulatory occlusion compared to 326 
Lowlanders  (32) . For these reasons, we hypothesized that Sherpa would have a lower MSNA 327 
response to the IHG/PECO protocol.  Counter to this hypothesis, we observed that Sherpa had a 328 
similar increase in MSNA during IHG/PECO.  It is worth noting that MSNA was lower in 329 
Sherpa compared to acclimatized Lowlanders through baseline and IHG/PECO.  Thus, the above 330 
noted mechanisms could still be involved in shifting the MSNA relationship lower, but keep the 331 
same gain of the response to metabolic stress.   332 
 333 
Neurovascular Reactivity between Lowlanders and Sherpa at Altitude 334 
During both apnea and IHG/ PECO reactivity protocols, there was no noted difference in 335 
pressor responses to apnea or IHG/PECO in Lowlanders at low or high altitudes, with exception 336 
to a lower TPR response under the PECO condition at altitude compared to sea level. Thus, the 337 
current study demonstrates that overall cardiovascular reactivity was preserved during altitude 338 
acclimatization 5050m. From the findings of both reactive conditions the vasoconstrictive 339 
response was greater in Sherpa during apnea, but not IHG/PECO, which was shown in the 340 
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indirect transduction findings. We postulate two explanations for this disparity: 1) the magnitude 341 
of the response to apnea was much larger than during the IHG/PECO protocol, and thus may 342 
have been more robust for identifying differences in pressor responses between groups; and 2) 343 
the lack of change in mean arterial pressure is representative of total systemic changes in TPR 344 
and cardiac output.  Thus, the modest increase in MSNA may not have had a significant 345 
influence on altering mean arterial pressure.  The subset of data evaluating brachial artery blood 346 
flow support this hypothesis.  Although our data do not support differences in the cardiovascular 347 
response to small muscle mass recruitment in Sherpa, we acknowledge previous data which 348 
suggests other cardiovascular adaptations in this population. Sherpa have previously been shown 349 
to exhibit greater capillary density within skeletal muscle  (19)  and improved ability to increase 350 
leg blood flow following 2 minutes of circulatory occlusion  (32) . Ezurum et al. (7)  351 
subsequently demonstrated that Tibetans have higher resting forearm blood flow and circulating 352 
NO by-products. These previous data support an improved dilatory capacity, but our data also 353 
support a lower resting sympathetic activity, a greater sympathetic reserve and greater vascular 354 
sensitivity to higher levels of sympathetic activity.  Together, this may serve as an important 355 
control mechanism for redirected blood and oxygen during stress. Thus, Sherpa appear to have 356 
developed improved cardiovascular efficiency that does not rely to the same extent on 357 
sympathetic hyperactivity relative to acclimatized Lowlanders. Whether this is expressed 358 
through other high altitude populations remains to be determined.  359 
 360 
Considerations 361 
 An interesting finding for Lowlanders was the lower total absolute MSNA responses to 362 
apnea at high altitudes, despite basal MSNA being augmented at 5050m. As the apnea duration 363 
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was shorter, in combination with a lower post-breakpoint SpO2 (indicative of an increase 364 
chemoreceptor activation) (8, 39) , it can be argued that apnea at altitude is a greater sympathetic 365 
stressor than it is at low altitude. However, the concurrent bradycardia which we have previously 366 
reported on  (3) likely limited sympathetic activation and could explain the appearance of 367 
abnormal MSNA burst patterns at 5050m. This demonstrates a potential sympathetic “ceiling 368 
effect” may have developed in Lowlanders, where further stress does not produce additional 369 
MSNA activation. In other words, there is less MSNA reserve available for responding to acute 370 
stress at altitude. MSNA outflow is limited to an individuals’ respective cardiac cycle, where a 371 
finite degree of sympathetic augmentation can occur during each R-R interval  (4, 24) . Whether 372 
Sherpa truly have additional MSNA reserve available during apnea, or simply reached their own 373 
respective sympathetic ceiling, cannot be confirmed due to us being unable to obtain sympathetic 374 
reactivity in Sherpa at Kathmandu. However, the absence of abnormal burst pattern and a lower 375 
average incidence of bursts in the cardiac cycles preceding break-point supports this premise.  376 
 377 
 378 
Though we report that MSNA is lower across both basal and reactivity conditions for 379 
Sherpa, the specific mechanism that contributes to this overall lower MSNA response has not yet 380 
been determined. During the transition between acute to chronic hypoxia exposure there is an 381 
apparent time-dependant sensitization for the peripheral chemoreceptors that results in 382 
progressively heightened MSNA  (5) . This is supported by a higher basal MSNA previously 383 
observed by Hansen and Sander  (13)  and further confirmed by Lundby et al.  (22) . If this were 384 
true then it could be argued that attenuated chemoreflex sensitivity in Sherpa should explain their 385 
lower basal MSNA. However, indirect measures of chemoreceptor sensitization do not appear to 386 
Downloaded from www.physiology.org/journal/ajpregu by Jonathan Moore (082.132.245.171) on January 8, 2020.
 19
explain the differences in MSNA between groups, as the current consensus (including more 387 
recent publishing from this expedition) demonstrate similar hypoxic ventilatory responses 388 
between acclimatized Lowlanders and Sherpa  (1, 3, 10) . Though we do not believe the 389 
peripheral chemoreflex is the primary driving mechanism for why sympathetic reactivity differs 390 
between groups; we cannot completely exclude it given that ventilatory and sympathetic 391 
responses may differ when under chemoreflex engagement  (20) .  Regardless, the lower MSNA 392 
noted for Sherpa is likely attributed to a combination of other reflexes.  These may include 393 
differences in long-term potentiation of central regulatory mechanisms, central resetting, or 394 
baroreflex-mediated changes between Lowlanders and Sherpa  (12, 28, 42) ; the latter is 395 
addressed in a parallel paper by this research group  (35) .   396 
 397 
Limitations 398 
As testing of Lowlanders and Sherpa occurred during the initial 10 days of being at 399 
5050m, we acknowledge that the findings within this study may be in part influenced by the 400 
respective date individuals were tested at 5050m. As previously stated we assessed the potential 401 
covariate of duration through Pearson’s correlation and follow up ANCOVA analysis, where 402 
neither burst frequency or incidence reached significance(P=0.065 and p=0.937). However, 403 
when examining baseline sympathetic function, and both sympathetic and vascular reactivity 404 
between groups, there was no relationship following correction for the day they were tested at 405 
5050m. We acknowledge the lack of relationship between duration of residency and resting 406 
MSNA may be due to our small sample size. Although there may exist a gradual increase in 407 
sympathetic activity following prolonged durations at altitude, this does not appear to have 408 
affected our results of the current study. Furthermore, Lundby et al.  (22)  also showed that 409 
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MSNA was similar in acclimatized Lowlanders between days 10 and 50 at 4100 m. MSNA 410 
therefore does not appear to increase further following several days at altitude, though the exact 411 
period is currently undefined. However, we also acknowledge that degree of sympathetic 412 
activation may be dose dependant with regards to the specific severity of hypoxic exposure  (31) 413 
. Whether MSNA shows further augmentation over the span of days-weeks should be considered 414 
for future studies. 415 
The use of voluntary apnea is a simple model of assessing muscle autonomic reactivity as 416 
it evokes both a quick and large sympathetic response. However, apnea tolerance can be 417 
objectively difficult to assess as duration can be affected by several factors including previous 418 
repetitive practice overall tolerance to apneic stress between individuals  (27) . This raises the 419 
question of whether Sherpa truly demonstrated a maximal apnea at altitude.  However, all 420 
experimental procedures and manoeuvres were explained to Sherpa in Nepali and trials were 421 
repeated if there was any confusion. In addition, Sherpa had both a similar apnea duration and 422 
drop in SpO2 to that of Lowlanders. 423 
Perspectives and Significance 424 
The current study demonstrates several novel findings, including that: 1) overall resting 425 
MSNA activity and reactivity to apneic stress is lower in Sherpa at altitude; 2) sympathetic 426 
reactivity to stress in acclimatized Lowlander appears to have be finite given the findings of a 427 
potential “sympathetic ceiling”; and 3.) overall vascular reactivity was preserved during altitude 428 
acclimatization 5050m in both Lowlanders and Sherpa, demonstrating that vascular 429 
responsiveness to sympathetic activation may differ between groups. However, the specific 430 
mechanisms that governs these differences between acclimatized Lowlanders and Sherpa is 431 
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uncertain. We propose that the observation of an apparent sympathetic plateauing observed in 432 
Lowlanders indirectly supports a potentially greater sympathetic reserve at altitude for Sherpa, 433 
though our findings from Kathmandu are underpowered to confirm this. Altered vascular 434 
responsiveness in Sherpa may be a beneficial adaptation to generational residency that prevents 435 
chronic hypertensive states while allowing greater vascular control when necessary to increased 436 
physical demands at altitude. In general, further research is needed in order to delineate 437 
underlying mechanisms that underpin autonomic and neurovascular control at high altitude in 438 
native Sherpa. 439 
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FIGURE CAPTIONS 455 
 456 
 457 
FIGURE 1: Integrated neurogram demonstrating sympathetic activity during baseline (left) and 458 
reactivity during apnea (right). Apnea shows last 10 cardiac cycles obtained prior to volitional 459 
breakpoint. Panel A,B,C. Example of Neurogram from the same male at 355m (A) and 5050m 460 
(B) against Sherpa at 5050m (C). Apnea at altitude caused prolonged burst periods and loss of 461 
characteristic burst “peak” in Lowlanders . However, these prolonged burst remained contained 462 
with a cardiac cycle.  Sherpa did not develop prolonged burst firing patterns at 5050m.  463 
 464 
FIGURE 2:  Integral burst area (delta % change relative to baseline, mean± SD; denoted as 465 
“#A” ) and incidence of bursts (% of individuals who exhibited a burst during the respective 466 
cardiac cycle, denoted as “#B”) within Lowlanders (n.=14) and Sherpa (n=8) during apnea. 467 
Values represent 10 cardiac cycles prior to volitional breakpoint (indicated by dashed red line 468 
along with mean apnea duration). Panel 1,2, Lowlanders at 344m (blue) and 5050m (orange), 469 
Panel 3, Sherpa at 5050m (red). Maximum integrated burst area was determined as the highest 470 
response during the 10 cardiac cycles for each participant. Burst incidence was calculated as the 471 
number of individuals (represented as a %) exhibiting a burst during that respective cardiac 472 
cycle. Lowlanders showed an increase in sympathetic activity prior to apnea breakpoint at both 473 
low and high altitude (P<0.05). Multiple comparisons were assessed for integral burst area using 474 
pre-planned contrasts of Lowlanders from low to high altitude  (paired t-tests), and Lowlanders 475 
to Sherpa at high altitude (unpaired t-tests) with an adjusted alpha value corrected for multiple 476 
comparisons.  Sherpa exhibited a smaller increase in burst area (P<0.05) versus Lowlanders at 477 
5050m. The incidence of bursts in Lowlanders prior to volitional breakpoint was 100% while 478 
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incidence of bursts in Sherpa was 88%. * Significant difference from respective baseline P<0.05; 479 
† Significantly different from Lowlanders at high altitude, P<0.05. 480 
 481 
FIGURE 3: Bar graph (Mean± SD) representing the absolute changes from baseline in 482 
normalized total peak SNA (au/min) and change in peak mean arterial pressure (mmHg) during 483 
apnea. The normalized SNA represents the sum of SNA across the duration of 10 cardiac cycles. 484 
The change in peak mean arterial pressure represents the change in peak blood pressure 485 
immediately following (between 0-15 seconds) apnea breakpoint.  Statistical analysis for 486 
normalized total peak SNA and change in mean arterial pressure was performed via one-way 487 
ANOVA between Lowlanders at low altitude, Lowlanders at High Altitude.  All groups 488 
exhibited a significant increase in MSNA and blood pressure. However, acclimatized 489 
Lowlanders (5050m) and Sherpa (5050m) exhibited a smaller change in total SNA compared to 490 
Lowlanders at low altitude (334m).  Acclimatized Lowlanders (5050m) and Sherpa (5050m) also 491 
had smaller blood pressure response compared to Lowlanders at low altitude (334m). * 492 
Significant increase with respect to baseline, P<0.05; † Significantly different from other groups, 493 
P<0.05, ‡ Significantly different from Lowlanders at 334m only, P<0.05. 494 
 495 
FIGURE 4:  Line graph representing absolute burst frequency (Denoted as “A”; bursts/min), 496 
incidence, (Denoted as “B”; bursts / 100 cardiac cycles) and total sympathetic activity (Denoted 497 
as “C”; au) in Lowlanders at low altitude (n=14; white circle), high altitude (n=14; black circle), 498 
and Sherpa at high altitude (n=6; black triangle) during the isometric handgrip and occlusion 499 
protocol. Burst frequency, incidence, and total SNA during baseline, IHG, and PECO protocols, 500 
a two-way repeated measures ANOVA compared the main and interaction effects in the 501 
distributions between conditions.Lowlanders at exhibited both an interactive and  main effect in 502 
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burst Frequency (P<0.001),  and incidence (P<0.001). Sherpa exhibited an overall lower burst 503 
frequency, incidence and total MSNA during the BL, IHG and PECO compared to acclimatized 504 
Lowlanders (each P<0.001). During IHG burst frequency (all P<0.001), burst incidence (all 505 
P<0.001) and total MSNA (all P<0.001)  were elevated significantly in Lowlanders at 344m and 506 
5050m, and Sherpa at 5050m respectively. No further increase in burst frequency or total MSNA 507 
occurred between IHG and PECO, although burst incidence climbed due to the concurrent return 508 
of heart rate to baseline during PECO (Figure 7). The increase in MSNA occurring with 509 
IHG/PECO was not different between groups. 510 
 511 
FIGURE 5. Line graph representing absolute Heart Rate (Denoted as “A”; bpm), Mean 512 
Arterial Pressure, (Denoted as “B”; mmHg) and Total Peripheral Resistance (Denoted as “C”; 513 
mmHg/L/min) in Lowlanders at low altitude (n=14; white circle), high altitude (n=14; black 514 
circle), and Sherpa at high altitude (n=6; black triangle) during the isometric handgrip and 515 
occlusion protocol. Heart rate, mean arterial pressure, and total peripheral resistance during 516 
baseline, IHG, and PECO protocols, a two-way repeated measures ANOVA compared the main 517 
and interaction effects in the distributions between conditions. While Sherpa tended to have an 518 
overall lower blood pressure (P<0.05), the absolute change in blood pressure response to IHG 519 
and PECO were similar between Sherpa (+15± 4 and +12± 6 mmHg) and Lowlanders  (+15± 6 520 
and +12± 8 mmHg)  at 5050m (Figure 5).   The change in total peripheral resistance was also 521 
similar between Sherpa (+2.6± 2.8 and +2.9± 2.9 mmHg/L/min) and Lowlanders  (-0.7± 1.9 and 522 
+0.6± 1.7 mmHg/L/min)  at 5050m .  Thus, unlike the apnea protocol we did not detect 523 
significant differences in neurovascular reactivity during IHG / PECO stress with altitude (in 524 
Lowlanders) or between groups (at 5050m).   525 
 526 
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 527 
Figure 6.  Line graph representing absolute Brachial Artery Flow (Denoted as “A”; mL/min), 528 
Brachial Artery Resistance , (Denoted as “B”; mmHg/mL/min) and Brachial Artery Conductance 529 
(Denoted as “C”;mmHg/L/min) in Lowlanders at low altitude (n=8; white circle), high altitude 530 
(n=8; black circle), and Sherpa at high altitude (n=4; black triangle) during the isometric 531 
handgrip and occlusion protocol. All vascular responses during baseline, IHG, and PECO 532 
protocols, a two-way repeated measures ANOVA compared the main and interaction effects in 533 
the distributions between conditions. Basal forearm blood flow was not different between 534 
Lowlanders at 344m (46± 39 mL/min), 5050m (22± 42 mL/min), or Sherpa at 5050m (56± 24 535 
ml/min). Both IHG and PECO saw no change in contralateral brachial blood flow for Sherpa 536 
(+29± 25 and +12± 8 L/min) and Lowlanders (+8± 23 and +2± 23 L/min) at 5050m.  The HG 537 
and PECO protocols did not result in a change in contralateral brachial resistance for Sherpa (-538 
0.3± 1.1 and -0.9± 1.9 mmHg/mL/min) and Lowlanders (-0.6± 1.0 and -0.2± 0.9 539 
mmHg/mL/min) at 5050m. There was a significant main effect for brachial artery conductance 540 
(P<0.05), with Lowlanders having a higher brachial artery conductance at altitude than Sherpa , 541 
though the absolute change during IHG and PECO were similar between Sherpa (-0.1± 0.3 and -542 
0.1± 0.4 mmHg/mL/min) and Lowlanders (+0.3± 0.3 and +0.5± 0.5 mmHg/mL/min) at 5050m. 543 
  544 
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TABLE 1: Participant demographics and metrics of basal neuro-cardiovascular function in lowlanders (at 








 344m (N = 14) 
5050m 
(N = 14) 
5050m 
(N = 8) 
Subject Demographics    
Age (years) 27±6 27± 6 32±13 
Height (m) 1.77±0.8 1.77± 0.08 1.68±0.08 
Weight (kg) 72.2±10.1 69.4± 8.6 63.7±10.1 
BMI (kg/m2) 23.1±2.8 22.2±2.5 22.8±3.5 
     Resting Cardiovascular Function    
Heart Rate (bpm) 61 ± 15 70 ± 15* 71± 5 
SPO2 (%) 98 ± 1 83 ± 3* 83 ± 4 
Systolic Pressure (mmHg) 119 ± 9 113 ± 13 111 ± 9 
Diastolic Pressure (mmHg) 66 ± 7 70 ± 10 65 ± 8 
Mean Pressure (mmHg) 84 ± 8 86 ± 11 84 ± 9 
 Cardiac Output (L/min) ♦ 5.9 ± 1.8 5.5 ± 1.4 6.0 ± 1.7 
Total Peripheral Resistance ♦ 15 ± 4 17 ± 4 16 ± 7 
Resting Sympathetic Function    
Burst Frequency (burst min-1) 11 ± 5 30 ± 7* 23 ± 11*† 
Burst Incidence (burst 100 HB -1) 25 ± 13 53 ± 15* 30 ± 13*† 
Burst Amplitude (% of peak) • 42.1± 22.2 46.7±7.9 46.3± 19.1 
Total Activity (au/min) 451 ± 206 1320 ± 520* 1103 ± 520* 
♦ Derived from Model Flow calculation. 
•Burst amplitude calculated as median and interquartile range 
* Significantly different from Lowlanders tested at low altitude (344m); p < 0.05. 
† Significantly different from Lowlanders tested at high altitude (5050m); p<0.05.  
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FIGURE 1 
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FIGURE 2 
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FIGURE 2 
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